Primary Record
FBHuman
- In stock
- 897 g
- Purity
- 98.6 %
- CAS
- 119911-68-1
Compound Identifiers & Properties
- CAS
- 119911-68-1
- PubChem CID
- 71308663
- SMILES
- C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC4=CNC=N4)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N)O
- Canonical SMILES
- CC(C)C[C@H](NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(N)=O)C(C)C)[C@@H](C)O)C(C)C)C(C)C)C(C)C
Names & Synonyms
- FBHuman
- alpha-CGRP (8-37) (human)
- CGRP 8-37 (human)
- alpha-Cgrp (8-37)
- Val(8)-phe(37)-cgrp
- Hcgrp (8-37)
- alpha-CGRP(8-37)[human]
- CGRP (Human, 8-37)
- CGRP8-37
- SCHEMBL29743043
- |A-CGRP 8-37
- CGRP(8-37)
- PCG-4232-V
- CGRP-(8-37)
- 119911-68-1
- AKOS024456445
- C139H230N44O38
- Calcitonin gene-related peptide (8-37)
- J337.758J
- C139-H230-N44-O38
- 8-Val-37-phe-calcitonin gene-related peptide
- 8-37-a-Calcitonin gene-related peptide(human)
- A16949
- Calcitonin Gene-Related Peptide 8-37 (human)
- alpha-Calcitonin gene-related peptide(8-37)[human]
- Calcitonin gene-related peptide, val(8)-phe(37)-
- Calcitonin Gene Related Peptide Fragment 8-37 human
- Calcitonin gene-related peptide, valyl(8)-phenylalanine(37)-
- Calcitonin Gene Related Peptide Fragment 8-37 human, >=97% (HPLC), powder
- (2S)-N-[(1S)-1-[({[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-{[(1S)-1-carbamoyl-2-phenylethyl]carbamoyl}ethyl]carbamoyl}pentyl]carbamoyl}-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]-2-methylpropyl]-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-{2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-{2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]propanamido]acetamido}-4-methylpentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]acetamido}acetamido)-3-methylbutanamido]-3-methylbutanamido]hexanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]butanediamide
- Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 ?-CGRP ( Human, 8-37)